ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,650, issued on Aug. 18, was assigned to National University of Singapore (Singapore).

"Recombinant bacteria and uses thereof" was invented by Yongliang Zhang (Singapore) and Chin Wen Png (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a recombinant, probiotic lactic acid bacterium, wherein the bacterium comprises a non-replicating plasmid vector comprising (a) a tumor suppressor gene or anti-inflammatory gene operably linked to a first promoter that directs expression of the tumor suppressor gene or anti-inflammatory gene in a mammalian cell, and (b) an adhesin gene operably linked to a second promoter that ...